Drawing for REVIVE RX

USPTO serial 99668854

REVIVE RX

Status 641Office Action
Filing date
Feb 25, 2026
Status date
Jun 24, 2026
Registration date
Examiner
BROWN,HERBERT C

Need help with REVIVE RX?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Deadline: September 24, 2026

Office Action issues

The USPTO issued an office action refusing your trademark due to potential confusion with an existing registration, requiring a valid physical domicile address, and requesting a disclaimer for descriptive wording.

Owner

  • Ainnocence Inc

    Mountain View, CA, US

Goods and services

ClassDescriptionStatusFirst use
042Pharmaceutical research servicesACTIVE

Prosecution history

DateCodeEvent
Jun 24, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 24, 2026GNRTNON-FINAL ACTION E-MAILED
Jun 24, 2026CNRTNON-FINAL ACTION WRITTEN
Jun 23, 2026DOCKASSIGNED TO EXAMINER
Jun 22, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 25, 2026MAFRAPPLICATION FILING RECEIPT MAILED
Feb 25, 2026NWAPNEW APPLICATION ENTERED

Related guidance